Brain implant allows ALS patient to control Amazon’s Alexa with thought: ‘Gives me back the independence that I’m losing’
To be able to manage important aspects of my environment and control access to entertainment gives me back the independence that I’m losing.”
Brain implant lets man with amyotrophic lateral sclerosis control Amazon's Alexa with his thoughts
A patient with a degenerative disease was able to command Amazon's Alexa digital assistant with his mind, the company behind the
Synchron Connects Brain Implant to Amazon Alexa
Synchron is one of several companies working to make brain-computer interfaces (BCIs) a reality. Earlier this summer, Synchron revealed one of its study participants could use the Apple Vision Pro VR headset thanks to the Synchron implant.
64-year-old ALS patient controls Alexa with just his thoughts
A 64-year-old ALS patient successfully controlled Alexa using his thoughts through a brain implant, allowing him to perform tasks like making video calls, playing music, and operating smart home devices.
Man controls Amazon Alexa with his thoughts, ‘It gives me back the independence’
An ALS patient manipulated Amazon's Alexa through a brain implant, enabling him to control devices and stream shows mentally. This advancement illustrates the potential of brain-computer interfaces to provide independence to those with degenerative diseases,
ALS patient uses brain chip to control Alexa, shop, stream with just thoughts
On Monday, Synchron, a brain-computer interface (BCI) company, announced this development, revealing that the 64-year-old patient, diagnosed with amyotrophic lateral sclerosis (ALS), can stream shows,
New research identifies potential therapeutic target for amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is the most common degenerative motor neuron disease ...
Too Old to Operate14h
CATS-A ARQ Measures Cognitive Impairment in ALS with High Accuracy
The following is a summary of “How to detect affect recognition alterations in amyotrophic lateral sclerosis,” published in the September 2024 issue of Neurology by Castelnovo et al. Researchers condu ...
FierceBiotech3d
After Alzheimer's stumble, Athira lays off 70% of workforce and pivots to ALS small molecule
Athira Pharma has been on a bumpy road in recent years, and, now, the company is restructuring and shedding weight to try to keep the journey going.  | Just a couple of weeks after announcing that its ...
Medscape7d
ALS Blood Test Promises Accurate, Earlier Diagnosis
A blood test has been shown to accurately identify patients with amyotrophic lateral sclerosis at early stages, which could ...
News Medical on MSN10d
New blood test achieves 98% accuracy in diagnosing ALS
A highly accurate diagnostic blood test has been developed for amyotrophic lateral sclerosis (ALS), a progressive ...
WebMD15d
Amyotrophic Lateral Sclerosis (ALS)
Familial ALS (FALS) runs in families. About 5% to 10% of people with amyotrophic lateral sclerosis have this type. Changes to a gene cause FALS. Parents pass the faulty gene to their children.
Prince William and Kate Middleton Support New Book About Late Rugby Star Who Died From ALS
Prince William and Kate Middleton have offered their support to Lindsey Burrow, the widow of late British rugby star Rob ...
News Medical13d
New target identified for potential ALS therapy
Oxidative stress, metabolic dysfunction, and neuroinflammation are well-known hallmarks of ALS, which gave the researchers a target for their quest to understand the disease: a group of enzymes called ...
EurekAlert!11d
Rapid new blood diagnostic test for ALS
Highly accurate determination of ALS using microRNA sequences will allow neurologists to make more rapid diagnoses, improving ...
The Lancet4d
Trial designs for motor neuron disease in the 21st century
Motor neuron diseases are a group of progressive and ultimately fatal neurodegenerative disorders of the motor system, ...
ALS News Today9h
Short course of treatment with RNS60 extends survival in ALS
A short course of treatment with RNS60, as an add-on to riluzole, extended the survival of ALS patients by about six months, ...